September 2019

Ebola breakthrough

Ebola could soon be “preventable and treatable”, after a trial of two drugs showed significantly improved survival rates.

Chlamydia vaccine on horizon

The first ever chlamydia vaccine to reach phase 1 clinical trial has been found to be safe and able to provoke an immune response.

Emergency and disaster situations

Warren Johns is one of the authors of the WHO book: Health laboratory facilities in emergency and disaster situations. He talks about his experiences, followed by a review of the book by Neil Bentley OBE from the National Infection Services.

Smart sensors for bandages

Scientists are developing smart sensors which can monitor the healing progress of a wound, eliminating the need to look underneath a bandage.

Sustainable pathology

With climate change and sustainability becoming a significant focal point for any sector, it’s hard to ignore healthcare’s need for transformation, argues Specialist Biomedical Scientist Carmen Holmberg.

Here to Help: Education and training standards

Now that September is here, Jocelyn Pryce, Deputy Head of Education at the IBMS, gives an update.

Dolly the manmade sheep

In an exclusive interview, Sir Ian Wilmut discusses genetic engineering, his recent Parkinson’s diagnosis and, of course, the most famous sheep in the world.

Blood test for Alzheimer’s

Randall Bateman is leading a team that has just come up with a blood test to screen people at risk of developing Alzheimer’s disease, years before the symptoms appear. 

The big question: “Why do we often undersell ourselves?”

This month we ask “Why do we often undersell ourselves?”

Targeting the spread of pancreatic cancer

An international team of scientists has revealed how aggressive pancreatic cancer cells change their environment to enable metastasis – the main cause of pancreatic cancer-related death.